(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are AFFLUENT MEDICAL, AGFA-GEVAERT, and AB SCIENCE.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| AFFLUENT MEDICAL (AFME.PA) | 2.07 | 14.36% | 2024-03-13 12:45:21 |
| AGFA-GEVAERT (AGFB.BR) | 1.22 | 13.59% | 2024-03-13 12:04:52 |
| AB SCIENCE (AB.PA) | 2.62 | 12.23% | 2024-03-13 12:44:43 |
| VALLOUREC (VK.PA) | 16.20 | 9.2% | 2024-03-13 13:24:27 |
| TERACT (TRACT.PA) | 0.62 | 8.45% | 2024-03-13 13:23:47 |
| EQVA (EQVA.OL) | 3.41 | 6.56% | 2024-03-13 12:26:07 |
| KOMPLETT (KOMPL.OL) | 11.52 | 5.69% | 2024-03-13 12:40:56 |
| POXEL (POXEL.PA) | 0.49 | 5.31% | 2024-03-13 13:21:43 |
| FUT.CLUBE PORTO (FCP.LS) | 1.20 | 5.26% | 2024-03-13 12:23:16 |
| HAFNIA LIMITED (HAFNI.OL) | 75.50 | 4.79% | 2024-03-13 12:40:22 |
The three biggest losers today are ABL Diagnostics, METABOLIC EXPLORER, and SOLOCAL GROUP.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| ABL Diagnostics (ABLD.PA) | 3.18 | -67.22% | 2024-03-13 12:44:52 |
| METABOLIC EXPLORER (METEX.PA) | 0.19 | -48.99% | 2024-03-13 13:20:23 |
| SOLOCAL GROUP (LOCAL.PA) | 0.05 | -41.72% | 2024-03-13 13:23:11 |
| PIERRE VAC BSA ACT (VACBS.PA) | 0.09 | -20% | 2024-03-13 13:21:32 |
| NAVAMEDIC (NAVA.OL) | 34.80 | -12.12% | 2024-03-13 12:41:22 |
| VIVORYON (VVY.AS) | 0.59 | -9.23% | 2024-03-13 12:04:31 |
| TECHSTEP (TECH.OL) | 8.25 | -8.03% | 2024-03-13 12:43:58 |
| MCPHY ENERGY (MCPHY.PA) | 1.70 | -7.47% | 2024-03-13 13:20:10 |
| EUROCASTLE INVEST. (ECT.AS) | 7.30 | -7.01% | 2024-03-13 12:01:56 |
| NORTHERN DRILLING (NODL.OL) | 0.39 | -6.99% | 2024-03-13 12:41:39 |
Winners today
1. AFFLUENT MEDICAL (AFME.PA)
14.36% Price Change
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
CAC 40 ended the session with AFFLUENT MEDICAL jumping 14.36% to €2.07 on Wednesday while CAC 40 jumped 0.62% to €8,137.58.
Earnings Per Share
As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.37%.
More news about AFFLUENT MEDICAL.
2. AGFA-GEVAERT (AGFB.BR)
13.59% Price Change
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. The company's Offset Solutions segment provides commercial, newspaper, and packaging printers; integrated prepress and printing solutions, including computer-to-plate systems using digital offset printing plates, pressroom supplies, and software for workflow optimization, color management, screening, and print standardization; and security printing software solutions. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides picture archiving and communication systems; hospital information system and clinical information systems; and integrated care solutions. Its Digital Print & Chemicals segment offers inkjet printers for sign and display printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; membranes to the hydrogen production industry, as well as for printable synthetic papers This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
BEL 20 ended the session with AGFA-GEVAERT rising 13.59% to €1.22 on Wednesday, after two successive sessions in a row of gains. BEL 20 fell 0.57% to €3,728.49, after five successive sessions in a row of gains, on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, AGFA-GEVAERT has a trailing twelve months EPS of €-1.34.
More news about AGFA-GEVAERT.
3. AB SCIENCE (AB.PA)
12.23% Price Change
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
CAC 40 ended the session with AB SCIENCE jumping 12.23% to €2.62 on Wednesday, following the last session’s upward trend. CAC 40 jumped 0.62% to €8,137.58, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.36.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AB SCIENCE’s stock is considered to be oversold (<=20).
Volatility
AB SCIENCE’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.04%, a negative 2.37%, and a positive 4.52%.
AB SCIENCE’s highest amplitude of average volatility was 2.26% (last week), 6.40% (last month), and 4.52% (last quarter).
More news about AB SCIENCE.
4. VALLOUREC (VK.PA)
9.2% Price Change
Vallourec S.A., through its subsidiaries, provides tubular solutions for the oil and gas, industry, and energy markets in Europe, North America, South America, Asia, the Middle East, and internationally. It operates through Tubes, Mine & Forests, and Holding Companies & Other segments. The company offers seamless tubes for refineries, petrochemical facilities, and floating liquefied natural gas plants, as well as production, storage, and offloading units; casings; tubings; VAM connections; rigid subsea line pipes, onshore rigid line pipes, and specialized tubes for transportation of oil and gas; and carbon steel and steel alloy tubes, hollow bars, and connections for the processing of industrial fluids, and oil and gas. Its oil and gas market services include assistance in lowering tubes, inspecting connections, and supervising assembly; repair services for its products and thread tubes inventory management; tube inspection, maintenance, and repair services; on-site services; preparation for drilling operations; well coordination and supply services based on the drilling programs; integrated solutions for the subsea line pipe market comprising welding, coating, insulation, logistics, and service agreements; and tube coating and welding services. The company's power generation market products and services comprise seamless tubes for steam generators. Its industrial market products and services include tubes and hollow bars, as well as circular, square, rectangular, and octagonal sections; tubular solutions for infrastructure construction; tubes and rings to manufacture cranes, construction machinery, agricultural machinery, and hydraulic cylinders; and tubes and axles for automotive manufacturers. The company is also involved in the iron ore production business. Vallourec S.A. was founded in 1899 and is based in Meudon, France.
CAC 40 ended the session with VALLOUREC rising 9.2% to €16.20 on Wednesday while CAC 40 rose 0.62% to €8,137.58.
Earnings Per Share
As for profitability, VALLOUREC has a trailing twelve months EPS of €2.07.
PE Ratio
VALLOUREC has a trailing twelve months price to earnings ratio of 7.83. Meaning, the purchaser of the share is investing €7.83 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.69%.
Sales Growth
VALLOUREC’s sales growth is 24.9% for the ongoing quarter and 18.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 5.52B for the twelve trailing months.
Volume
Today’s last reported volume for VALLOUREC is 3258080 which is 241.2% above its average volume of 954883.
More news about VALLOUREC.
5. TERACT (TRACT.PA)
8.45% Price Change
Teract S.A. operates in retail business in Europe. The company operates through Garden Centre Retailer and Marketer segments. It operates garden centers and pet care shops under the Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brand names. The company also operates in the fresh, local, and organic produce sector under Frais d'Ici and Bio&Co brands with food outlets. It operates 1,597 stores. The company is based in Paris, France.
CAC 40 ended the session with TERACT rising 8.45% to €0.62 on Wednesday while CAC 40 jumped 0.62% to €8,137.58.
Earnings Per Share
As for profitability, TERACT has a trailing twelve months EPS of €0.62.
PE Ratio
TERACT has a trailing twelve months price to earnings ratio of 0.99. Meaning, the purchaser of the share is investing €0.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.98%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 53%, now sitting on 902.1M for the twelve trailing months.
Volume
Today’s last reported volume for TERACT is 127826 which is 222.8% above its average volume of 39598.
Yearly Top and Bottom Value
TERACT’s stock is valued at €0.62 at 21:40 EST, way under its 52-week low of €1.87.
More news about TERACT.
6. EQVA (EQVA.OL)
6.56% Price Change
Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.
Oslo Børs Benchmark Index_GI ended the session with EQVA jumping 6.56% to €3.41 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.96% to €1,291.47.
Earnings Per Share
As for profitability, EQVA has a trailing twelve months EPS of kr-0.32.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.
Moving Average
EQVA’s worth is way above its 50-day moving average of kr2.92 and way higher than its 200-day moving average of kr3.07.
Yearly Top and Bottom Value
EQVA’s stock is valued at kr3.41 at 21:40 EST, way below its 52-week high of kr4.00 and way above its 52-week low of kr2.56.
Volume
Today’s last reported volume for EQVA is 114223 which is 382.99% above its average volume of 23649.
More news about EQVA.
7. KOMPLETT (KOMPL.OL)
5.69% Price Change
Komplett ASA operates as an online retailer of electronics and IT products in Norway, Sweden, and Denmark. The company operates through three segments: Business to Consumer (B2C), Business to Business (B2B), and Distribution. It offers consumer electronics and business solutions, including computer components, gaming, PCs, household electronics, and other computer-related products, as well as brown and white goods, and cloud-based IT solutions and services. It operates webshops under the Komplett brand; and retail stores under the Webhallen brand. The company's B2B operations include sales to companies and public entities/institutions under the Komplett Bedrift and Komplett Företag. It also distributes products to resellers and other entities under the Itegra brand. The company was formerly known as Norkom ASA and changed its name to Komplett ASA in December 2002. Komplett ASA was founded in 1991 and is headquartered in Sandefjord, Norway.
Oslo Børs Benchmark Index_GI ended the session with KOMPLETT jumping 5.69% to €11.52 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.96% to €1,291.47, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, KOMPLETT has a trailing twelve months EPS of kr-1.51.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.39%.
Volume
Today’s last reported volume for KOMPLETT is 131650 which is 66.16% above its average volume of 79228.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 15.86B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KOMPLETT’s stock is considered to be overbought (>=80).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 92% and 160%, respectively.
More news about KOMPLETT.
8. POXEL (POXEL.PA)
5.31% Price Change
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
CAC 40 ended the session with POXEL jumping 5.31% to €0.49 on Wednesday while CAC 40 rose 0.62% to €8,137.58.
Earnings Per Share
As for profitability, POXEL has a trailing twelve months EPS of €-1.08.
Volume
Today’s last reported volume for POXEL is 101702 which is 62.32% below its average volume of 269913.
Yearly Top and Bottom Value
POXEL’s stock is valued at €0.49 at 21:40 EST, way below its 52-week high of €0.95 and way higher than its 52-week low of €0.30.
More news about POXEL.
9. FUT.CLUBE PORTO (FCP.LS)
5.26% Price Change
Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.
PSI ended the session with FUT.CLUBE PORTO jumping 5.26% to €1.20 on Wednesday while PSI slid 0.53% to €6,110.35.
Earnings Per Share
As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €0.94.
PE Ratio
FUT.CLUBE PORTO has a trailing twelve months price to earnings ratio of 1.28. Meaning, the purchaser of the share is investing €1.28 for every euro of annual earnings.
More news about FUT.CLUBE PORTO.
10. HAFNIA LIMITED (HAFNI.OL)
4.79% Price Change
Hafnia Limited owns and operates oil product tankers. It operates through Long Range II, Long Range I, Medium Range (MR), Handy size, Chemical-Handy, and Chemical-MR segments. The company transports petroleum oil products, vegetable oil, and easy chemicals to national and international oil companies, and chemical companies, as well as trading and utility companies. It provides ship owning, ship-management, chartering, investment, and agency office services. The company is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with HAFNIA LIMITED jumping 4.79% to €75.50 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.96% to €1,291.47.
Earnings Per Share
As for profitability, HAFNIA LIMITED has a trailing twelve months EPS of kr18.25.
PE Ratio
HAFNIA LIMITED has a trailing twelve months price to earnings ratio of 4.14. Meaning, the purchaser of the share is investing kr4.14 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.45%.
More news about HAFNIA LIMITED.
Losers Today
1. ABL Diagnostics (ABLD.PA)
-67.22% Price Change
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. It offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S RNA; ultragene assays for viral detection of SARS CoV-2, dengue, and Zika virus; microbiological specimen transport and collection kits, which include RNA and saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation system, and sanger sequencing reagents. The company also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. It sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is based in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
CAC 40 ended the session with ABL Diagnostics sliding 67.22% to €3.18 on Wednesday while CAC 40 jumped 0.62% to €8,137.58.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €0.1.
PE Ratio
ABL Diagnostics has a trailing twelve months price to earnings ratio of 31.8. Meaning, the purchaser of the share is investing €31.8 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.12%.
Yearly Top and Bottom Value
ABL Diagnostics’s stock is valued at €3.18 at 21:40 EST, way below its 52-week low of €4.50.
More news about ABL Diagnostics.
2. METABOLIC EXPLORER (METEX.PA)
-48.99% Price Change
METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.
CAC 40 ended the session with METABOLIC EXPLORER falling 48.99% to €0.19 on Wednesday while CAC 40 rose 0.62% to €8,137.58.
Earnings Per Share
As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.
More news about METABOLIC EXPLORER.
3. SOLOCAL GROUP (LOCAL.PA)
-41.72% Price Change
Solocal Group S.A. provides digital services in France and internationally. Its services include connect that allows VSEs and SMEs to manage their digital presence on PagesJaunes and various mobile application or a web interface, as well as manages interactions between professionals and their customers; and booster that allows companies to increase their digital visibility in the Web. The company was formerly known as PagesJaunes Groupe and changed its name to SoLocal Group S.A. in June 2013. Solocal Group S.A. was founded in 1896 and is headquartered in Boulogne-Billancourt, France.
CAC 40 ended the session with SOLOCAL GROUP falling 41.72% to €0.05 on Wednesday while CAC 40 jumped 0.62% to €8,137.58.
Earnings Per Share
As for profitability, SOLOCAL GROUP has a trailing twelve months EPS of €-0.28.
Moving Average
SOLOCAL GROUP’s worth is way below its 50-day moving average of €0.09 and way under its 200-day moving average of €0.11.
More news about SOLOCAL GROUP.
4. PIERRE VAC BSA ACT (VACBS.PA)
-20% Price Change
CAC 40 ended the session with PIERRE VAC BSA ACT falling 20% to €0.09 on Wednesday, after sequential sessions in a row of losses. CAC 40 rose 0.62% to €8,137.58, following the last session’s upward trend on what was a somewhat up trend trading session today.
Yearly Top and Bottom Value
PIERRE VAC BSA ACT’s stock is valued at €0.09 at 21:40 EST, below its 52-week low of €0.10.
More news about PIERRE VAC BSA ACT.
5. NAVAMEDIC (NAVA.OL)
-12.12% Price Change
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NAVAMEDIC dropping 12.12% to €34.80 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.96% to €1,291.47.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 29.49. Meaning, the purchaser of the share is investing kr29.49 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.76%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr34.80 at 21:40 EST, way under its 52-week high of kr43.90 and way higher than its 52-week low of kr31.00.
Volatility
NAVAMEDIC’s last week, last month’s, and last quarter’s current intraday variation average was 1.86%, 0.16%, and 1.38%.
NAVAMEDIC’s highest amplitude of average volatility was 1.86% (last week), 1.86% (last month), and 1.38% (last quarter).
More news about NAVAMEDIC.
6. VIVORYON (VVY.AS)
-9.23% Price Change
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
AEX-Index ended the session with VIVORYON dropping 9.23% to €0.59 on Wednesday while AEX-Index dropped 0.07% to €860.33.
Earnings Per Share
As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VIVORYON’s stock is considered to be oversold (<=20).
Volatility
VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.54%, a negative 1.50%, and a positive 3.24%.
VIVORYON’s highest amplitude of average volatility was 14.92% (last week), 5.16% (last month), and 3.24% (last quarter).
More news about VIVORYON.
7. TECHSTEP (TECH.OL)
-8.03% Price Change
Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with TECHSTEP falling 8.03% to €8.25 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.96% to €1,291.47, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, TECHSTEP has a trailing twelve months EPS of kr-2.02.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.27%.
Moving Average
TECHSTEP’s value is under its 50-day moving average of kr8.59 and way below its 200-day moving average of kr10.84.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TECHSTEP’s stock is considered to be oversold (<=20).
Earnings Before Interest, Taxes, Depreciation, and Amortization
TECHSTEP’s EBITDA is 12.51.
Volatility
TECHSTEP’s last week, last month’s, and last quarter’s current intraday variation average was 1.25%, 0.82%, and 1.97%.
TECHSTEP’s highest amplitude of average volatility was 2.09% (last week), 2.65% (last month), and 1.97% (last quarter).
More news about TECHSTEP.
8. MCPHY ENERGY (MCPHY.PA)
-7.47% Price Change
McPhy Energy S.A. provides hydrogen production and distribution equipment for hydrogen energy, hydrogen mobility, and industrial hydrogen markets. The company offers alkaline electrolyzers; hydrogen storage and transportation solutions; and fuel cell systems. It also develops hydrogen stations; and provides integrated hydrogen solutions. The company operates in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. McPhy Energy S.A. was incorporated in 2007 and is headquartered in Grenoble, France.
CAC 40 ended the session with MCPHY ENERGY dropping 7.47% to €1.70 on Wednesday while CAC 40 jumped 0.62% to €8,137.58.
Earnings Per Share
As for profitability, MCPHY ENERGY has a trailing twelve months EPS of €-1.77.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.8%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MCPHY ENERGY’s stock is considered to be overbought (>=80).
Volatility
MCPHY ENERGY’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.47%, a negative 1.15%, and a positive 2.42%.
MCPHY ENERGY’s highest amplitude of average volatility was 2.55% (last week), 2.30% (last month), and 2.42% (last quarter).
Moving Average
MCPHY ENERGY’s worth is way below its 50-day moving average of €2.61 and way below its 200-day moving average of €5.08.
Volume
Today’s last reported volume for MCPHY ENERGY is 139504 which is 32.26% above its average volume of 105475.
More news about MCPHY ENERGY.
9. EUROCASTLE INVEST. (ECT.AS)
-7.01% Price Change
Eurocastle Investment Limited is a publicly traded closed-ended investment company that focuses on investing in performing and nonperforming loans and other real estate related assets primarily in Italy. The Company is Euro denominated and is listed on Euronext Amsterdam under the symbol “ECT”. Eurocastle is managed by an affiliate of Fortress Investment Group LLC, a leading global investment manager. For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com.
AEX-Index ended the session with EUROCASTLE INVEST. dropping 7.01% to €7.30 on Wednesday while AEX-Index fell 0.07% to €860.33.
Earnings Per Share
As for profitability, EUROCASTLE INVEST. has a trailing twelve months EPS of €-0.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.03%.
Sales Growth
EUROCASTLE INVEST.’s sales growth is negative 113.8% for the ongoing quarter and negative 113.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.8%, now sitting on 495k for the twelve trailing months.
More news about EUROCASTLE INVEST..
10. NORTHERN DRILLING (NODL.OL)
-6.99% Price Change
Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING sliding 6.99% to €0.39 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.96% to €1,291.47.
Earnings Per Share
As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-5.84.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.
Volume
Today’s last reported volume for NORTHERN DRILLING is 317577 which is 86.7% below its average volume of 2389420.
Moving Average
NORTHERN DRILLING’s worth is way below its 50-day moving average of kr0.47 and way under its 200-day moving average of kr11.39.
Volatility
NORTHERN DRILLING’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.52%, a negative 0.49%, and a positive 6.93%.
NORTHERN DRILLING’s highest amplitude of average volatility was 8.22% (last week), 5.46% (last month), and 6.93% (last quarter).
Yearly Top and Bottom Value
NORTHERN DRILLING’s stock is valued at kr0.39 at 21:40 EST, way under its 52-week high of kr33.90 and way above its 52-week low of kr0.31.
More news about NORTHERN DRILLING.
Stay up to date with our winners and losers daily report
